Advanced Therapies Europe 2020

29TH - 30TH SEPTEMBER 2020



Michael Leek

Michael Leek

Chief Executive, TC Biopharm

Recently presented the 'Scottish Life-Sciences Entrepreneurial Business Leadership' award, Michael is CEO of TC BioPharm, developing clinical-stage CAR-T  immunotherapies.

Active in the cell therapy sector for 30 years, Michael has developed ten different cell-based products to clinic including the world’s first allogeneic cell therapy to undergo multi-national (EU, US, Canada) phase III evaluation; he was previously responsible for moving Intercytex from a pre-clinical startup, to an AIM-listed company.

  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd